Moderna Inc.’s COVID-19 vaccine won backing from a panel of experts who advise U.S. regulators, setting the stage for its shot to be the second vaccine cleared in the U.S. in as many weeks.
December 17, 2020- °®¶¹´«Ã½
- Government
- Business
- Technology
- Equipment
- Safety
- Fuel
- Logistics
- Autonomous
- Top 100/Top 50
- More
- Media
- Videos
- Podcasts
- Photo Galleries
- TT Newsmakers
- TT Special Event Series
- Smart Speaker Briefings
- Commentary
- Perspective
- Fun & Games
- Cartoons
- Crossword Puzzle
- Special Coverage
- Event Coverage
- Upcoming Events
- Submit Your Event
- Data
- Stocks
- Resource Center
- Webinars
- Whitepapers
- Reference
- Government & Industry Resources
- U.S. Government Sites
- State Government Sites